Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- FDA/FTC Join Regulatory Efforts against Hormone-Related Product Claims
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have announced actions against a number of companies marketing unapproved “alternative hormone therapies,” targeting unproven disease claims; FDA said it has sent Warning Letters to 16 dietary supplement and hormone cream marketers; FTC is issuing letters that notify 34 websites that include unsubstantiated claims.
- FDA/FTC Join Regulatory Efforts against Hormone-Related Product Claims
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) have announced actions against a number of companies marketing unapproved “alternative hormone therapies,” targeting unproven disease claims; FDA said it has sent Warning Letters to 16 dietary supplement and hormone cream marketers; FTC is issuing letters that notify 34 websites that include unsubstantiated claims.
- FTC Warns Web Sites Peddling Hormone Replacement Therapy Alternatives to Review Their Claims
Federal Trade Commission staff sent warning letters to 34 Web site operators making claims that products advertised as natural alternatives to hormone replacement therapy will prevent or treat diseases, such as cancer, heart disease, or osteoporosis. The warning letters advise these sellers that their marketing claims may be illegal.
- FTC Warns Web Sites Peddling Hormone Replacement Therapy Alternatives to Review Their Claims
Federal Trade Commission staff sent warning letters to 34 Web site operators making claims that products advertised as natural alternatives to hormone replacement therapy will prevent or treat diseases, such as cancer, heart disease, or osteoporosis. The warning letters advise these sellers that their marketing claims may be illegal.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- ICS Inc. continues to expand
In response to demand for QA & Regulatory consulting services, company announces appointment of new staff including Kara Sundberg, Lynda Burch, Joyce Malakoff and Michelle Harris.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- AHPA Challenges 'Illegal Listing' of Areca Nut on California Proposition 65
AHPA) filed extensive comments on November 21, 2005, to provide input and challenge a proposal by the State of California to list areca nut (the seed of Areca catechu) and betel quid as chemicals known by the State to cause cancer.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- FSANZ Invites Comment About Draft Health Claims Standard
Proposed standard has two levels of claims - general claims aboub content or general health about a non-serious disease, and then hig-level health claims in relation to a serious disease or condition.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Report on the Codex Nutrition Committee Meeting in Bonn, Germany
Particpants report little progress on key issues for the food supplements industry, with further substantive discussions to wait for the 2006 Thaaiand meeting.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- Traditional Medicines Congress calls for comments on 'Ideal Regulatory Model'
Nine national organizations have collaborated to release the first public draft of “A Proposed Regulatory Model for Traditional Medicines: Guiding Assumptions and Key Components.” Document presents ideas for a new model for the regulation of traditional medicines in the United States.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- FSA Receives Plant sterols application
DDO Processing has asked that their phytosterols extract from tall oil be regarded as equivalent to a previously approved tall oil extract.
- Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products
subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China.
- Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products
subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China.
- Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products
subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China.
- Global Pharmatech Receives SFDA Approval for Three New Botanical Drug Products
subsidiary, Jilin BCT Pharmaceutical Co., Ltd., recently received three new drug approvals from the State Food and Drug Administration of the People's Republic of China, allowing Jin Lian Hua Capsule, Gong Yan Kang Granules and Wei Kang Ling Capsule to be marketed and sold in China.
- Bi-national Food Agency Wants Comment on Proposed Changes to Regulations
Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food.
- Bi-national Food Agency Wants Comment on Proposed Changes to Regulations
Food Standards Australia New Zealand (FSANZ) has published proposed changes to the Australia New Zealand Food Standards Code including regulations dealing with nutrition, health and related claims and use of an intense sweetener in food.
- FDA Acts to Seize Ephedra-Containing Dietary Supplements
The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon.
- FDA Acts to Seize Ephedra-Containing Dietary Supplements
The U.S. Attorney's Office for the Eastern District of Texas and the U.S. Attorney's Office for the District of Oregon filed Complaints for Forfeiture against Nature's Treat Energy Plus #1, a dietary supplement that contains ephedra, an herbal source of ephedrine alkaloids. The supplement is distributed by Nature's Treat, Inc., Gainesville, Texas and ACD Distributing, LLC, of Eugene, Oregon.
- Ontario Government Regulating Traditional Chinese Medicine
Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility.
- Ontario Government Regulating Traditional Chinese Medicine
Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility.
- Ontario Government Regulating Traditional Chinese Medicine
Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility.
- Ontario Government Regulating Traditional Chinese Medicine
Highlights of the proposed legislation include the creation of a self-governing regulatory college, a defined scope of practice and restricted titles that only members of the profession may use, and Restricting the performance of acupuncture to members of regulated health professions and to persons who perform acupuncture as part of an addiction treatment program within a health facility.
- Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1
The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)).
- Canada: Proposed Amendments to Schedule A Claims Rules Published in Canada Gazette, Part 1
The proposed amendments would allow natural health products to make schedule A health claims, currently prohibited under the Food and Drugs Act (subsections 3(1) and 3(2)).
- Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG
The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids.
- Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG
The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids.
- Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG
The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids.
- Neptune Technologies & Bioressources Inc. Announces Strategic Alliances with Degussa AG
The alliance between Neptune and Degussa AG includes a two-tier project with a common objective to expand the Neptune pipeline. With Degussa’s AG expertise in supercritical CO2 extraction, Neptune will complete the enhancement of Neptune Krill Oil properties, customized for different functional foods and also complete the extraction process, isolation and industrial production of Neptune’s novel phospholipids.
- FDA Acts to Protect Public from Fraudulent Avian Flu Therapies
Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza.
- FDA Acts to Protect Public from Fraudulent Avian Flu Therapies
Agency has issued warning letters recently to nine companies marketing bogus flu products behind claims that their products could be effective against preventing the avian flu or other forms of influenza.
- FDA to Require Food Manufacturers to List Food Allergens
Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods.
- FDA to Require Food Manufacturers to List Food Allergens
Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods.
- FDA to Require Food Manufacturers to List Food Allergens
Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods.
- FDA to Require Food Manufacturers to List Food Allergens
Effective January 1, 2006, the Food and Drug Administration (FDA) is requiring food labels to clearly state if food products contain any ingredients that contain protein derived from the eight major allergenic foods.
- Canada- Recall of Chaparral-Containing Products
Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns.
- Canada- Recall of Chaparral-Containing Products
Health Canada and the Canadian Food Inspection Agency have issued an advisory recommending that consumers not use oral products conatining chaparral because of serious health concerns.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Pharming Announces GRAS Filing On Human Lactoferrin
Company has completed its human lactoferrin (hLF) filing for a Generally Recognized as Safe (GRAS) notification with the US Food and Drug Administration (FDA), with the data reviewed by an independent scientific expert panel.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
Searchable AHPA NDI Database Developed by AHPA and NPIcenter
The American Herbal Products Association (AHPA) and NPIcenter have collaborated to create a database to access all notifications the Food and Drug Administration (FDA) has received for new dietary ingredients (NDIs). The AHPA NDI Database launches on Monday, December 5, 2005, with a one-day-only open access trial period, before the subscription period begins.
The database can be searched by numerous relevant fields, including the generic or brand name of every 75-day notice (botanical and non-botanical), the Latin binomial of herbs, and the name of the company that made the submission. The database also provides a concise “outcome statement” for each file that quickly summarize how FDA has responded to every notification, and the problems, if any, that the agency identified for each.
“New ingredients are key to the supplement industry’s future and the AHPA NDI Database will be a valuable resource for firms that are filing the required notification prior to marketing an NDI, said Michael McGuffin, president of AHPA. “By accessing and reviewing other relevant NDI notifications, companies will be better prepared to file complete submissions and thereby prevent delays to market entry.”
The Dietary Supplement Health and Education Act (DSHEA) requires manufacturers or distributors of an NDI — an ingredient not sold before DSHEA went into effect in 1994 — to provide information to FDA that is the basis for a conclusion that the ingredient is reasonably expected to be safe (New dietary ingredients that are articles used as food in a form in which the food has not been chemically altered are exempt form the notification requirement described here.).
Since DSHEA passed, FDA has posted almost 300 NDI notifications on its dockets website. However, the only organization provided is by the FDA-assigned report numbers, which makes individual reports very difficult to locate. Even when found, it is impossible to know without opening and examining the entire file (which can run to hundreds of pages) whether a filing was successful or whether (and why) FDA objected to the notification. The AHPA NDI Database was specifically designed to provide faster and more informative access to filed notifications.
The database will be maintained on an ongoing basis; future NDI filings and FDA responses will be promptly added to the system. Special introductory access fees for AHPA members are $125 per year per site / $40 per day per site, and for non-members are $495 per year per site / $125 per day per site. The open-access trial period runs 9 a.m.–6 p.m. Eastern, Monday, December 5, only.
The AHPA NDI Database is accessible at http://ndi.npicenter.com/. |